The WACC of SAGE Therapeutics Inc (SAGE) is 6.8%.
Range | Selected | |
Cost of equity | 8.50% - 11.20% | 9.85% |
Tax rate | 26.20% - 27.00% | 26.60% |
Cost of debt | 5.00% - 5.00% | 5.00% |
WACC | 6.1% - 7.4% | 6.8% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 1.02 | 1.14 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 8.50% | 11.20% |
Tax rate | 26.20% | 27.00% |
Debt/Equity ratio | 1 | 1 |
Cost of debt | 5.00% | 5.00% |
After-tax WACC | 6.1% | 7.4% |
Selected WACC | 6.8% | |